Skip to content

Mandibular Advancement Device on Sleep Quality in Obstructive Sleep Apnea Patients

Impact of Treatment With Mandibular Advancement Device (MAD) on Sleep Quality in Patients With Obstructive Sleep Apnea (OSA)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06169228
Acronym
DAMOSA
Enrollment
50
Registered
2023-12-13
Start date
2021-01-01
Completion date
2024-12-31
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Brief summary

Sleep is an important factor that influences long-term quality of life with known health consequences. Obstructive sleep apnea, the most prevalent disease that disturbs sleep, is considered a public health problem. Treatment with continuous positive airway pressure is cost effective and reverses the clinical consequences but there is a percentage of patients who do not tolerate it or leave it without treatment and with potential future health complications. Mandibular advancement device can be a valid and well tolerated alternative, it is known that it reduces apnea-hypopnea index, but its effect on the improvement of sleep quality is evaluated by polysomnography that interferes with the quality of sleep. There is an ambulatory monitoring device for sleep quality and circadian rhythms, which can register prolonged periods of time, under natural conditions and at a lower cost than a polysomnography. This pilot project assesses whether mandibular advancement device is an effective and well tolerated alternative in the treatment of obstructive sleep apnea to improve the quality of life and sleep in the medium and long term.

Detailed description

Design: observational, unicentric prospective. 50 patients / year will be included, for 3 years. The care protocol (evaluation and follow-up) of the multidisciplinary sleep unit will be followed. Demographic and anthropometric data will be collected. The dental status of the temporo-mandibular joint will be assessed. Radiological records, home respiratory polygraphy, ambulatory monitoring device for 7 days , quality of life questionnaires before and after treatment.

Interventions

The multidisciplinary sleep unit assessment and follow-up protocol will be followed for this group of patients based on the Spanish Clinical Practice Guideline of the Spanish Sleep Society (SES) on the use of mandibular advancement devices in the treatment of patients with obstructive sleep apnea

Sponsors

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Obstructive Sleep Apnea Syndrome * opt for mandibular advancement device as 1st treatment alternative * opt for mandibular advancement device due to intolerance to continuous positive airway pressure

Exclusion criteria

* Patient with orthodontics, malocclusion and periodontal or temporomandibular joint disease who, after assessment by dentistry contraindicates it. * Central Sleep apnea (more than 50% of central events in the baseline polygraph). * Under 18 years old. * Pregnancy * Comorbidities that can potentially alter sleep architecture. * Psychophysical inability to complete questionnaires. * Not obtaining informed consent.

Design outcomes

Primary

MeasureTime frameDescription
mandibular advancement device on sleep quality3 yearsTolerability and efficacy of treatment with a mandibular advancement device (MAD) on sleep quality in patients with Obstructive Sleep Apnea (OSA) measured by the ambulatory circadian monitoring device.
ambulatory circadian monitoring device3 yearsTo evaluate improvement in sleep quality with mandibular advancement devices measured by fragmentation and stability of sleep by the circadian monitoring sensor.
home sleep apnea test3 yearsTo evaluate the number of residual apneic breaths measured by home home sleep apnea test

Secondary

MeasureTime frameDescription
Obstructive sleep apnea severity3 yearsEvaluate the severity by home sleep apnea test
questionnaire SF-123 yearsmultidimensional health related quality of life
questionnaire EuroQoL3 yearsstandardized non-disease specific instrument to describe and value health-related quality of life
questionnaire iPAQ3 yearsInternational Physical Activity Questionnaire

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026